An interventional study of Secure text messaging in Congestive Heart Failure, Diabetes and Renal Failure, sponsored by University of Pennsylvania. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-04-10.
Sponsored by University of Pennsylvania · Not applicable, Interventional, and Health services research
In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.
Inpatient health care providers such as physicians and nurses spend up to one-third of their time communicating with other health care providers. Many of these communications have shifted mediums from handwritten notes and face-to-face conversations to phone calls and paging systems. More recently the rapid adoption of smartphones has led to the use of mobile-enabled technologies using smartphones such as text messaging and email. While these technologies may offer ease and fit better within the clinical workflow, they often send patient information through unsecure cellular or internet connections. Mobile secure text messaging may address these issues by encrypting data and allowing for asynchronous or synchronous communication between individual providers or groups of providers. In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
Browse Heart Failure studies →University of Pennsylvania is the lead sponsor of 1,635 studies on the registry; 239 are open to participants now.
Of its 154 completed or terminated interventional studies of FDA-regulated products, 104 (68%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients admitted to hospital floors without any other intervention.
Patients admitted to hospital floors on which physicians and other staff are able to communicate with each other (not to the patient) using mobile secure text messaging.
Device: Secure text messaging
A smartphone and web application that allows physicians and other health care professionals to communicate to each other by secure text message
Change in length of stay
Change in inpatient length of stay from baseline to 6 months
Time frame: 6 months
Change in 30 day hospital readmissions
Change in 30 day hospital readmissions from baseline to 6 months
Time frame: 6 months
Change in inpatient mortality
Change in inpatient mortality from baseline to 6 months
Time frame: 6 months
Change in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAPs) scores
Change in HCAP scores from baseline to 6 months
Time frame: 6 months
This study is withdrawn, as verified in Apr 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Pennsylvania